FIND YOUR FINANCIAL EDGE
Enter to search Esc to close

3286 articles found for "investing"

Laboratory test tubes and pipette in a pharmaceutical research setting
Investing Feb 26, 2026

Revolution Medicines Burned Through $1.1 Billion in a Year With Zero Revenue, but Three FDA Breakthrough Designations and the Race to Cure RAS-Driven Cancers Could Make It the Most Important Biotech Story of the Decade

Revolution Medicines reported a $1.1 billion net loss for 2025 with zero product revenue, but three FDA breakthrough therapy designations for its RAS-targeted cancer drugs position it to crack a $40 billion oncology market.

The Money Unlock Editorial Team 8 min read